Frontier IP Group Plc

Cordiant Digital Infrastructure has secured two new customer agreements at its Hudson Interxchange data centre in New York, lifting contracted capacity to around 80% of the floor's saleable space. Billing on the first contract starts in September, with full deployment expected by year-end. Separately, Helium One Global's Colorado joint venture completed its first helium sale under a short-term offtake agreement after its second commercial helium trailer delivery, shifting focus to recurring sales and cash flow. Active Energy Group is expanding its UAE strategy beyond AI data centres into water, energy and critical infrastructure, noting that growing AI facilities need secure water supplies for cooling. Gaming Realms reported a 9% rise in core content licensing revenue in the first half despite a sharp increase in UK gambling tax, and has now entered 33 regulated markets including Alberta on its first day of legalised online gaming. Frontier IP Group portfolio company Pulsiv appointed Delta Matrix as its first manufacturing partner for products using its energy-efficient OSMIUM power conversion technology, targeting a market of around 600 million USB-enabled socket installations per year. Allergy Therapeutics appointed former HSBC banker Helge Weiner-Trapness as executive chairman as it explores a dual primary listing in Hong Kong.

Seeing Machines has won a new driver monitoring contract with a European carmaker worth around $5 million in lifetime revenue, as new EU safety rules make the technology mandatory on new vehicles. Production starts in 2028, with the system built into a rear-view mirror for easy deployment across multiple platforms. Frontier IP portfolio company Cambridge Raman Imaging has secured a €400,000 European grant to scale up its AI-powered pharmaceutical quality control technology and appointed a China-based distributor with over 100 customers globally. ImmuPharma has appointed Thermo Fisher Scientific to develop and manufacture the finished form of its experimental diabetes treatment Kapiglucagon, completing the main manufacturing partnerships alongside Swiss group Bachem, which is handling the active ingredient. MP Evans grew crude palm oil production 11% to 192,300 tonnes in the first half, supported by higher harvests across its Indonesian estates, with pricing holding firm at around $873 per tonne. Ariana Resources says its Tavşan gold mine in Türkiye has completed its ramp-up and is now processing ore at the required rate of at least 4,000 tonnes a day, with gold recovery tracking at around 70%. 88 Energy has moved its Augusta-1 Alaska well closer to a first-quarter 2027 spud after securing a rig and camp, and prospective resources at South Prudhoe have been upgraded by 35%.

Solvonis Therapeutics says new data supports its lead alcohol use disorder programme ahead of a planned Phase 2b trial, with CEO Anthony Tennyson noting the results could streamline development and open access to a market of around 15 million US adults. Tertiary Minerals has started its biggest-ever drilling programme in Zambia, aiming to define a maiden resource while testing for extensions and a potentially deeper sulphide system. CelLBxHealth is reshaping its strategy around cancer diagnostics and new pharma partnerships, with collaborations with AstraZeneca and AdventHealth potentially expanding clinical use of its Parsortix platform. Coinsilium Group says Bitcoin remains just one part of its growth story, as it also targets opportunities in AI, prediction markets and blockchain infrastructure. Eco Buildings Group has begun building its AI-enabled manufacturing platform in Albania, designed to boost efficiency and support global expansion. Frontier IP Group says a €211 million funding boost for portfolio company 2D Photonics marks a major milestone, with CEO Neil Crabb also highlighting progress across its AI, energy and healthcare investments.

Tower Resources has raised £400,000 to bolster working capital while it waits on government approvals in Namibia and Cameroon, with both farm-out deals potentially completing as early as July. Buccaneer Energy reported an 18% rise in proved reserves in an independent review tied to its bank credit facility, with the borrowing base confirmed at $4.45 million and more growth expected as production ramps up. Light Science Technologies secured up to £1.66 million in orders for its passive fire protection division since April's RLUK Injection acquisition, becoming a vertically integrated business spanning installation and material supply. Eco Buildings Group has started building a second-generation AI-enabled manufacturing line in Albania, the first major use of its recent £2.35 million fundraise, with the new line expected to be operational by the fourth quarter. Fieldwork Robotics, backed by Frontier IP Group, picked up a £300,000 investment from SEED Innovations to roll out its soft fruit harvesting robots, with multi-robot fleets potentially on farms from 2027 if trials succeed. ImmuPharma flagged new research suggesting its lead drug candidate could help treat glioblastoma, an aggressive brain cancer, while its main focus remains autoimmune disease.

Frontier IP Group CEO Neil Crabb discussed the company's recent fundraising and portfolio progress with Proactive's Stephen Gunnion. The raise will support operations, help portfolio companies reach scale-up and commercialisation milestones, and expand science centre activities in Cambridge. A key highlight was 2D Photonics securing state aid clearance for a €211 million grant to build a facility demonstrating photonics technology for AI and defence applications. Crabb also covered Pulsiv's energy efficiency technology, encouraging animal challenge study results at The Vaccine Group, Alusid's scale-up plans, GraphEnergyTech's work replacing silver with graphene in solar panels, and Cambridge Raman Imaging's materials analysis technology.

Arrow Exploration Corp has brought its Icaco-2 well in Colombia on production at around 830 barrels per day gross, taking total corporate output to approximately 5,000 barrels of oil equivalent per day. CEO Marshall Abbott says the Icaco discovery may be material to Arrow, with horizontal and vertical development wells already planned. Frontier IP Group PLC has raised £4 million through a placing and subscription at 12p per share, with six directors participating in the subscription element, and a retail offer through BookBuild aims to raise a further £400,000 before closing at 5pm on 18 June. RC365 Holding PLC has signed a point-of-sale agreement with StarCruises International to deploy its RC3.0 payments platform across cruise operations in Asia, including cryptocurrency acceptance and multi-language support. Coiled Therapeutics has appointed two senior oncologists to a newly formed medical advisory board guiding its lead cancer drug AO-252 through phase I trials, with Professor Guru Sonpavde and Dr Alexander Spira shaping clinical strategy as the programme moves toward expansion cohorts in the second half of 2026. Genflow Biosciences Ltd has been invited to present results from its SLAB dog longevity study at the Animal Longevity Summit in Toronto in October, with the study evaluating its SIRT6 gene therapy in aged beagles concluding this month. Pan African Resources PLC will join the FTSE 250 from 23 June, following the court sanction of its all-share acquisition of Emmerson Resources, and also joins the FTSE 350, FTSE All-Share and related indices.